3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
3
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gynecologic
20
Gastrointestinal
20
Thoracic
3
Other solid neoplasm
3
Tumor-Agnostic
1
Conditions
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Ovarian Neoplasms
2
Mesothelioma
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
Injections
17
Cisplatin
15
Carboplatin
15
Oxaliplatin
11
Gemcitabine
11
pembrolizumab
8
Capecitabine
8
toripalimab
7
Paclitaxel
7
Etoposide
7
Cyclophosphamide
7
Pemetrexed
6
Irinotecan
6
Drug Therapy
6
spartalizumab
5
fludarabine
5
camrelizumab
5
Vincristine
5
Radiotherapy
5
Leucovorin
5
tislelizumab
4
apatinib
4
anlotinib
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Fluorouracil
4
Docetaxel
4
Bevacizumab
4
tremelimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Hyperthermic Intraperitoneal Chemotherapy
×
Other solid neoplasm
×
Clear all
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled